Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Divestments (2023 - 2024)

Angiodynamics (ANGO) has disclosed Divestments for 2 consecutive years, with $34.5 million as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Divestments changed N/A year-over-year to $34.5 million, compared with a TTM value of $34.5 million through Nov 2024, down 65.5%, and an annual FY2024 reading of $134.5 million, changed N/A over the prior year.
  • Divestments was $34.5 million for Q1 2024 at Angiodynamics, down from $100.0 million in the prior quarter.
  • Across five years, Divestments topped out at $100.0 million in Q3 2023 and bottomed at $34.5 million in Q1 2024.